Large Language Models as Patient Education Tools in Hypothyroidism: A Cross-Sectional Analysis of Dietary, Pharmacological, and Safety Recommendations
DOI:
https://doi.org/10.12775/JEHSS.2026.88.68691Keywords
Hashimoto’s thyroiditis, Artificial Intelligence, chatgpt, Patient education, Hypothyroidism, PharmacotherapyAbstract
Background. Hashimoto’s thyroiditis (HT) is the most common cause of hypothyroidism worldwide and requires lifelong management. Due to the chronic nature of the disease and persistent symptoms despite biochemical euthyroidism, patients frequently seek online advice on dietary restrictions, supplementation, and pharmacotherapy. Large Language Models (LLMs) such as ChatGPT are increasingly used as sources of patient education; however, their consistency with established clinical guidelines, particularly those relevant to European and Polish populations, remains insufficiently evaluated.
Aim. This study aimed to conduct a comprehensive cross-sectional analysis of the accuracy, safety, and concordance of ChatGPT-4o responses with international clinical guidelines and clinical practice across four domains: diet/lifestyle, pharmacotherapy, supplementation, and common myths/safety.
Materials and Methods., Thirty-five standardized patient prompts reflecting real-world clinical questions were analyzed. Responses generated by ChatGPT-4o (January 2026) were assessed using a 3-point concordance scale based on recommendations from the Polish Endocrine Society (PTE), European Thyroid Association (ETA), and relevant peer-reviewed literature.
Results. Overall concordance with clinical guidelines was high (91.4%). The strongest performance was observed in pharmacotherapy-related questions and safety-critical scenarios, including pregnancy and drug interactions. Minor limitations concerned dosing nuances for certain supplements, where the AI occasionally adopted a more optimistic approach than conservative clinical recommendations.
Conclusions. ChatGPT shows high potential as a supportive educational tool for patients with hypothyroidism, providing guidance largely consistent with Evidence-Based Medicine and current PTE/ETA standards. However, due to limited nuance in “grey area” topics, it should complement rather than replace professional endocrinological consultation.
References
1. Ragusa F, Fallahi P, Elia G et al. Hashimoto’s thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best PractRes Clin Endocrinol Metab. 2019;33(6):101367. https://doi.org/10.1016/j.beem.2019.101367
2. Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med 2022;132(3):16222. https://doi.org/10.20452/pamw.16222
3. Ott J, Promberger R, Kober F et al. Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011;21(2):161-7. https://doi.org/10.1089/thy.2010.0191
4. Wiesner A, Gajewska D, Paśko P. Levothyroxine Interactions with Food and Dietary Supplements–A Systematic review. Pharmaceuticals (Basel). 2021;14(3):206. https://doi.org/10.3390/ph14030206
5. Meneses JK, Muniz DA, Moroto D, Martins JRM, Janovsky CCPS. The Influence of Health Literacy on the Control of Hypothyroidism in Patients Under Levothyroxine Treatment. Clin Endocrinol (Oxf). 2026;104(2):167-74. https://doi.org/10.1111/cen.70047
6. Metzger MJ, Flanagin AJ. Credibility and trust of information in online environments: the use of cognitive heuristics. J Pragmat 2013;59:210-20. https://doi.org/10.1016/j.pragma.2013.07.012
7. Sallam M. ChatGPT Utility in Healthcare Education, Research, and Practice: Systematic Review on the Promising Perspectives and Valid Concerns. Healthcare (Basel) 2023;11(6):887. https://doi.org/10.3390/healthcare11060887
8. Kung TH, Cheatham M, Medenilla A et al. Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models. PLOS Digit Health. 2023;2(2):e0000198. https://doi.org/10.1371/journal.pdig.0000198
9. Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell 2023;6:1169595. https://doi.org/10.3389/frai.2023.1169595
10. Hubalewska-Dydejczyk A, Trofimiuk-Müldner M, Ruchała M et al. Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology. Endokrynol Pol 2021;72(5):425-88. https://doi.org/10.5603/EP.a2021.0089
11. Płudowski P, Kos-Kudła B, Walczak M et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients 2023;15(3):695. https://doi.org/10.3390/nu15030695
12. Gietka-Czernel M. Profilaktyka niedoboru jodu (Iodine prophylaxis). Postepy Nauk Med. 2015;28(12):839-45.
13. Pearce SHS, Brabant G, Duntas LH et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. EurThyroid J 2013;2(4):215-28. https://doi.org/10.1159/000356507
14. Lazarus J, Brown RS, Daumerie C, Hubalewska-DydejczykA, Negro R, Vaidya B. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur Thyroid J 2014;3(2):76-94. https://doi.org/10.1159/000362597
15. Jonklaas J, Bianco AC, Bauer AJ et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-751. https://doi.org/10.1089/thy.2014.0028
16. Centanni M, Benvenga S, Sachmechi I. Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report. J Endocrinol Invest 2017;40(12):1289-301. https://doi.org/10.1007/s40618-017-0706-y
17. Ihnatowicz P, Drywień M, Wątor P, Wojsiat J. The importance of nutritional factors and dietary management of Hashimoto’s thyroiditis. Ann Agric Environ Med 2020;27(2):184-93. https://doi.org/10.26444/aaem/112331
18. Liontiris MI, Mazokopakis EE. A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients. Points that need more investigation. Hell J Nucl Med 2017;20(1):51-6. doi:10.1967/s00244991050; https://pubmed.ncbi.nlm.nih.gov/28315909/
19. Winther KH, Rayman MP, Bonnema SJ, Hegedüs L. Selenium in thyroid disorders - essential knowledge for clinicians. Nat Rev Endocrinol 2020;16(3):165-76. https://doi.org/10.1038/s41574-019-0311-6
20. Rybka Z, Kamińska M, Moczyróg K et al. The Impact of Nutritional and Dietary Factors on Hashimoto’s Thyroiditis: a Comprehensive Review. Qual Sport 2024;18:53755. https://doi.org/10.12775/QS.2024.18.53755
21. Kasprzak A, Mańkowska A, Truchta M et al. Vitamin D supplementation in patients with Hashimoto’s disease. J Educ Health Sport 2024;53:125-36. https://doi.org/10.12775/JEHS.2024.53.009
22. Asik M, Gunes F, Binnetoglu E et al. Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance. Endocrine 2014;46(2):279-84. https://doi.org/10.1007/s12020-013-0065-1
23. Skelin M, Lucijanić T, Klarić DA et al. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clin Ther 2017;39(2):378-403. https://doi.org/10.1016/j.clinthera.2017.01.005
24. Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab2014;99(12):4481-6. https://doi.org/10.1210/jc.2014-2684
25. Talaei A, Ghorbani F, Asemi Z. The Effects of Vitamin D Supplementation on Thyroid Function in Hypothyroid Patients: A Randomized, Double-blind, Placebo-controlledTrial. Indian J Endocrinol Metab 2018;22(5):584-8. https://doi.org/10.4103/ijem.IJEM_603_17
26. Huwiler VV, Maissen-Abgottspon S, Stanga Z et al. Selenium Supplementation in Patients with Hashimoto Thyroiditis: ASystematic Review and Meta-analysis of Randomized Clinical Trials. Thyroid 2024;34(3):295-313. https://doi.org/10.1089/thy.2023.0556
27. Peng B, Wang W, Gu Q, Wang P, Teng W, Shan Z. Effects of different supplements on Hashimoto’s thyroiditis: a systematic review and network meta-analysis. Front Endocrinol (Lausanne) 2024;15:1445878. https://doi.org/10.3389/fendo.2024.1445878
28. Nordio M, Basciani S. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto’s patients with subclinical hypothyroidism. Eur Rev Med Pharmacol Sci 2017;21(2 Suppl):51-9. https://pubmed.ncbi.nlm.nih.gov/28724185/
29. Ferrari SM, Fallahi P, Di Bari F, Vita R, Benvenga S, Antonelli A. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. Eur Rev Med Pharmacol Sci 2017;21(2 Suppl):36-42. https://pubmed.ncbi.nlm.nih.gov/28724175/
30. Bornstein SR, Allolio B, Arlt W et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab2016;101(2):364-89. https://doi.org/10.1210/jc.2015-1710
31. Ruggeri RM, Trimarchi F, Giuffrida G et al. Autoimmune comorbidities in Hashimoto’s thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol 2017;176(2):133-41. https://doi.org/10.1530/EJE-16-0737
32. U.S. Food and Drug Administration. The FDA warns that biotin may interfere with lab tests: FDA safety communication. Published November 28, 2017. Updated November 5, 2019. Accessed January 15, 2025.
33. Abbott RD, Sadowski A, Alt AG. Efficacy of the Autoimmune Protocol Diet as Part of a Multi-disciplinary, Supported Lifestyle Intervention for Hashimoto’s Thyroiditis. Cureus. 2019;11(4):e4556. https://doi.org/10.7759/cureus.4556
34. Basolo A, Begaye B, Hollstein T et al. Effects of Short-Term Fasting and Different Overfeeding Diets on ThyroidHormones in Healthy Humans. Thyroid 2019;29(9):1209-1219. https://doi.org/10.1089/thy.2019.0237
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Patryk Hebda, Mateusz Kubicki, Andrii Bilyk, Maria Król, Przemysław Kołodziej, Roman Cemaga, Adam Wolski, Natalia Marta Bruska, Ewa Szplit, Katarzyna Więckowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 316
Number of citations: 0
